Production and Distribution of Investigational Ghrelin Vaccines
Award Notice Posted
- Solicitation number
- NIH-NIAAA-2015-05
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Awarded
- to Scripps Research Institute
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- HHSN275201500006I Federal IDV award
- NAICS code
- 541711 Research and Development in Biotechnology
- PSC
- Not on record
Notice details come from SAM.gov. Updated .
Notice text
The National Institutes of Health (NIH), National Institute on Alcohol Abuse and Alcoholism (NIAAA) is planning to issue an RFP for an Indefinite/Delivery, Indefinite/Quantity (IDIQ) Task Order contract for the Production and Distribution of Investigational Ghrelin Vaccines. This will be a full and open competition IDIQ Task Order contract.
This acquisition is for a new requirement and will operate under an Indefinite/Delivery, Indefinite/Quantity (IDIQ) Task Order contract. The objectives of this acquisition are to synthesize vaccines against ghrelin hormone, evaluate effectiveness and selectivity of vaccine treatment from blood plasma samples (from animals), ship vaccines to intramural and extramural investigators and provide supporting data for vaccine synthesis methods and efficacy.
The RFP will be made available electronically only via the FedBizOpps website (http://www.fbo.gov). Offerors are responsible for routinely checking the FedBizOpps website for any possible solicitation amendments that may be issued. This notice does not commit the Government to award a contract. No collect calls will be accepted. No facsimile transmissions will be accepted. It is the Offerors responsibility to monitor FedBizOpps at WWW.fbo.gov for the release of the solicitation and any amendments.
Files
| File | Type | Posted |
|---|---|---|
| Amendment-1_RFP-NIH-NIAAA-2015-05.pdf | ||
| RFP-NIH-NIAAA-2015-05-w-Attachments_FBO.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity